The HemoCue Glucose, Albumin, and Hemoglobin A1c Systems: Enable Right Decisions at the Point of Care. Issue 1 (March 2017)

• Record Type: Journal Article
• Authors: Eriksson, Annika
• Is Part Of: Point of care. Volume 16:Issue 1(2017)
• Publication Date: 2017-03
• Subjects: HemoCue -- glucose -- albumin -- HbA1c -- diabetes -- microalbuminuria -- kidney disease; Point-of-care testing -- Periodicals; Point-of-Care Systems -- standards -- Periodicals; 616.075
• DOI: 10.1097/POC.0000000000000129
• Languages: English
• ISSNs: 1533-029X

Abstract

Abstract : Abstract: Diabetes care is complex requiring prevention and management to minimize complications. Point-of-care testing (POCT) has been found to have a positive impact on diabetes management, and studies have described an improvement in patient satisfaction and glycemic control as a result of immediate feedback to the patient. The HemoCue POCT technology directed toward diabetes management includes glucose and hemoglobin A1c devices as well as urine analyses to screen for microalbuminuria and nephropathy. HemoCue offers laboratory-accurate POCT solutions that are fast and easy to use with factory-calibrated analyzers and minimum maintenance required. With data management solutions, patient safety can be optimized making sure that the right tests are performed by the right person for the right patient.